The purpose of this study was to review the experience with fallopian tube
carcinoma in Queensland and to compare it with previously published data. T
hirty-six patients with primary fallopian tube carcinoma treated at the Que
ensland Gynaecological Cancer Center from 1988 to 1999 were reviewed in a r
etrospective clinicopathologic study. All patients had primary surgery and
31/36 received chemotherapy postoperatively. Abnormal vaginal bleeding (15/
36) and abdominal pain (14/36) were the most common presenting symptoms at
the time of diagnosis. Median follow-up was 70.3 months and the median over
all survival was 68.1 months. Surgical stage I disease (P = 0.02) and the a
bsence of residual tumor after operation (P = 0.03) were the only factors a
ssociated with improved survival. Twenty of the 36 patients (55%) presented
with stage I disease and survival was 62.7% at 5 years. No patient with po
stoperative residual tumor survived.
The majority of the patients with fallopian tube carcinoma present with sta
ge I disease at diagnosis, but their survival probability is low compared w
ith that of other early stage gynecological malignancies. If primary surgic
al debulking cannot achieve macroscopic tumor clearence, the chance of surv
ival is extremely low.